GlaxoSmithKline PLC Stock Forecast - Naive Prediction
| GSK Stock | 1,340 3.50 0.26% |
The Naive Prediction forecasted value of GlaxoSmithKline PLC on the next trading day is expected to be 1,396 with a mean absolute deviation of 15.19 and the sum of the absolute errors of 941.55. GlaxoSmithKline Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC stock prices and determine the direction of GlaxoSmithKline PLC's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of GlaxoSmithKline PLC's historical fundamentals, such as revenue growth or operating cash flow patterns.
GlaxoSmithKline |
GlaxoSmithKline PLC Naive Prediction Price Forecast For the 30th of November
Given 90 days horizon, the Naive Prediction forecasted value of GlaxoSmithKline PLC on the next trading day is expected to be 1,396 with a mean absolute deviation of 15.19, mean absolute percentage error of 333.53, and the sum of the absolute errors of 941.55.Please note that although there have been many attempts to predict GlaxoSmithKline Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that GlaxoSmithKline PLC's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
GlaxoSmithKline PLC Stock Forecast Pattern
| Backtest GlaxoSmithKline PLC | GlaxoSmithKline PLC Price Prediction | Buy or Sell Advice |
GlaxoSmithKline PLC Forecasted Value
In the context of forecasting GlaxoSmithKline PLC's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. GlaxoSmithKline PLC's downside and upside margins for the forecasting period are 1,395 and 1,398, respectively. We have considered GlaxoSmithKline PLC's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of GlaxoSmithKline PLC stock data series using in forecasting. Note that when a statistical model is used to represent GlaxoSmithKline PLC stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 125.7581 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 15.1864 |
| MAPE | Mean absolute percentage error | 0.0105 |
| SAE | Sum of the absolute errors | 941.5548 |
Predictive Modules for GlaxoSmithKline PLC
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as GlaxoSmithKline PLC. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for GlaxoSmithKline PLC
For every potential investor in GlaxoSmithKline, whether a beginner or expert, GlaxoSmithKline PLC's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. GlaxoSmithKline Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in GlaxoSmithKline. Basic forecasting techniques help filter out the noise by identifying GlaxoSmithKline PLC's price trends.GlaxoSmithKline PLC Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GlaxoSmithKline PLC stock to make a market-neutral strategy. Peer analysis of GlaxoSmithKline PLC could also be used in its relative valuation, which is a method of valuing GlaxoSmithKline PLC by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
GlaxoSmithKline PLC Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of GlaxoSmithKline PLC's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of GlaxoSmithKline PLC's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
GlaxoSmithKline PLC Market Strength Events
Market strength indicators help investors to evaluate how GlaxoSmithKline PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GlaxoSmithKline PLC shares will generate the highest return on investment. By undertsting and applying GlaxoSmithKline PLC stock market strength indicators, traders can identify GlaxoSmithKline PLC entry and exit signals to maximize returns.
| Accumulation Distribution | 43405.77 | |||
| Daily Balance Of Power | (0.22) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1339.5 | |||
| Day Typical Price | 1339.83 | |||
| Price Action Indicator | (0.75) | |||
| Period Momentum Indicator | (3.50) | |||
| Relative Strength Index | 36.74 |
GlaxoSmithKline PLC Risk Indicators
The analysis of GlaxoSmithKline PLC's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in GlaxoSmithKline PLC's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting glaxosmithkline stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.901 | |||
| Standard Deviation | 1.21 | |||
| Variance | 1.47 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in GlaxoSmithKline Stock
GlaxoSmithKline PLC financial ratios help investors to determine whether GlaxoSmithKline Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GlaxoSmithKline with respect to the benefits of owning GlaxoSmithKline PLC security.